Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00006495
What this trial is testing

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableStudy completedNCT02384395
What this trial is testing

Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection

Who this might be right for
HIVAcute HIV Infection
University of North Carolina, Chapel Hill 40
Not applicableStudy completedNCT00001075
What this trial is testing

The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Not applicableStudy completedNCT03001128
What this trial is testing

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Who this might be right for
HIV-1 Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 61
Post-approval studies (Phase 4)Study completedNCT02082652
What this trial is testing

A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy

Who this might be right for
HIVContraception
University of Pittsburgh 60
Post-approval studies (Phase 4)Study completedNCT00931463
What this trial is testing

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Who this might be right for
HIV Infections
Kirby Institute 558
Not applicableStudy completedNCT00429845
What this trial is testing

Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial

Who this might be right for
HIV Infections
Hospital de Clinicas de Porto Alegre 80
Testing effectiveness (Phase 2)Study completedNCT00005001
What this trial is testing

Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune)

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 40
Not applicableStudy completedNCT00831207
What this trial is testing

Beta-2 Microglobulin and Serum Cytokines x HAART

Who this might be right for
HIV Patients
UPECLIN HC FM Botucatu Unesp 109
Not applicableStudy completedNCT00585793
What this trial is testing

Relationship Between HIV-1 Subtype and ARV Response

Who this might be right for
HIV Infections
University of Wisconsin, Madison 108
Early research (Phase 1)Study completedNCT02568332
What this trial is testing

Assess the Safety of Hep C Vaccine Candidates in HIV Seropositive Individuals

Who this might be right for
Hepatitis C Infection
University of Oxford 20
Large-scale testing (Phase 3)Study completedNCT00711009
What this trial is testing

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Who this might be right for
Human Immunodeficiency Virus Infection
Abbott 206
Testing effectiveness (Phase 2)Looking for participantsNCT07202546
What this trial is testing

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

Who this might be right for
HIV Infections
ViiV Healthcare 186
Large-scale testing (Phase 3)Study completedNCT01797445
What this trial is testing

Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIVHIV Infections
Gilead Sciences 872
Not applicableStudy completedNCT01054586
What this trial is testing

Fosamprenavir in Pts With Hepatic Impairment

Who this might be right for
Infection, Human Immunodeficiency Virus
GlaxoSmithKline 167
Large-scale testing (Phase 3)Study completedNCT00158470
What this trial is testing

Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 100
Not applicableStudy completedNCT03454373
What this trial is testing

Long Term Follow-Up of Food and Cash Assistance for HIV-Positive Men and Women on Antiretroviral Therapy in Tanzania

Who this might be right for
Hiv
University of California, Berkeley 800
Post-approval studies (Phase 4)Study completedNCT01275625
What this trial is testing

Combivir And Maraviroc In Antiretroviral Naive Subjects In Russia

Who this might be right for
HIV
ViiV Healthcare 98
Not applicableStudy completedNCT02098525
What this trial is testing

Clinical Outcomes of Cryptococcal Meningitis Among HIV-infected Patients in the Era of Antiretroviral Therapy

Who this might be right for
Cryptococcal MeningitisHIV/AIDS
Mahidol University 195
Testing effectiveness (Phase 2)Study completedNCT00799136
What this trial is testing

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

Who this might be right for
Lymphoma, AIDS RelatedHIV Infections
Ontario Clinical Oncology Group (OCOG) 6
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation